Global Telepathology Service Market By Systems (Dynamic, Static, Hybrid); By Application (Diagnosis, Education, Research, Others); By End User (Hospitals, Diagnostic Centers and Pathology Clinics, Pharmaceutical and Biotech Companies, Academic Institutes, Research Organizations); By Region (U.S., Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Telepathology refers to the transmission of patient information and pathology images through telecommunication links. The technology facilitates various activities including consultations, primary diagnosis, frozen sections and quality assurance. There are numerous communication modalities used for performing these activities including real-time video microscopy, email, whole slide imaging (WSI), static-dynamic robotic microscopy along with hybrid devices with robotic microscopy and WSI capabilities. Absence of best practice guidelines, basic standards along with regulatory issues is restraining the telepathology service market growth. However, government authorities are undertaking relevant steps to expand its application areas across diverse practice settings. The Food and Drug Administration (FDA) in 2017 approved the commercialization of WSI, providing further growth and diversification opportunities to various vendors operating in the industry.
Telepathology is being increasingly used by a wide range of laboratories to establish direct communication with the patients and deliver pathological services more efficiently. Increased penetration of internet connectivity is supplementing the growth of telepathology service market in the developing countries. Moreover, the solution enables obtaining sub-specialty expertise through digital means without the need to manually transport the glass slides. This has simultaneously assisted in improving the turnaround times, eliminate redundant paperwork along with providing enhanced access to patients situated in remote locations. Furthermore, an advanced source of revenue for the pathologists through expanded consultative practices is serving as an excellent opportunity for the medical practitioners
Digital pathology, a dynamic form of telepathology system, enables efficient management and interpretations of information generated by digitized glass slides. In the telepathology industry, technology is largely contributing towards drug development, education and tissue based research activities amongst others. It helps to drive down cost, improve patient care and in the overall enhancement of operational efficiency. Integration of artificial intelligence and data mining with telepathology services showcases huge growth potential for telepathology services market in the forthcoming years. According to World Health Organization (WHO), cancer was identified to be among the major cause of death, accounting for more than 9.6 million deaths in 2018. Hence, rapid and appropriate diagnosis of the disease, has emerged as an essential criteria for the medical practitioners. Telepathology service market participants are proactively directing their initiatives towards innovation of advanced pathology platforms for more accurate and faster diagnosis. Aindra Systems, a healthcare IT Company, has developed artificial intelligence (AI)-based computational pathology platform, ASTRA, for detecting cervical cancers. The technology enables analysis of pap smear samples at the point-of-care, thereby reducing the turnaround time.
North America region holds the largest market share in the global telepathology service market, owing to the availability of well-equipped infrastructure and greater adoption of advanced technology. Massive investments being made into further advancement of the technology has propelled the expansion of the market in the region. Deep Lens, an Ohio-based digital pathology startup obtained an early funding of US$ 3.2 Million in 2018 towards the development of AI-based platform enabling pathologists to diagnose cancer disease among patients more accurately and in a timely manner. The platform, through application of advanced AI functionalities, allows undertaking specific diagnostic tests instantly. Simultaneously, Asia Pacific region is expected to witness maximum growth over the forecast period owing to faster adoption of advance technologies in China, India and South Korea. Hence, large scale investment by market participants is influencing the market growth in the regions.
The global telepathology service market revenue stood at US$ 637.61 million in the year 2018 and is expected to grow at a CAGR of 12.2% during the forecast period of 2019 - 2027. The study analyzes the market in terms of revenue across all the major markets.
Global Telepathology Service Market Revenue (US$ Million), 2017 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of global telepathology service market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global telepathology service market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.
The primary market participants in the global telepathology service market include Diagnostics Instruments, Inc., eVisit Telemedicine Solutions, Leica Biosystems Nussloch Gmbh, Meyer Instruments Inc., Remote Medical Technologies, Teleconsult Europe, Washington University in St. Louis, UNILABS SA, Apollo Tele Health Services, F. Hoffmann-La Roche Ltd., General Electric Company, Olympus Corporation, and SRL Diagnostics amongst others.
Telepathology Service Market
- By Systems
- Dynamic
- Static
- Hybrid
- By Application
- Diagnosis
- Education
- Research
- Others
- By End User
- Hospitals
- Diagnostic Centers and Pathology Clinics
- Pharmaceutical and Biotech Companies
- Academic Institutes
- Research Organizations
- By Geography
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic
- Denmark
- Finland
- Iceland
- Norway
- Sweden
- Rest of Nordic
- The Benelux Union
- Belgium
- the Netherlands
- Luxemburg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- GCC Countries
- Southern Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Telepathology Service Market
6. Market Synopsis:
Telepathology Service Market
7. Telepathology Service Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Telepathology Service Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Telepathology Service Market
7.6. Industry
Gross Margin Overview
7.7. Porter’s
Five Force Analysis
8. Global Telepathology Service Market Analysis and Forecasts,
2019 – 2027
8.1. Overview
8.1.1. Global
Telepathology Service Market Revenue (US$ Mn)
8.2. Global
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Systems
8.2.1. Dynamic
8.2.1.1. Definition
8.2.1.2. Market Penetration, 2018
8.2.1.3. Market Estimation, 2013 – 2018
8.2.1.4. Market Forecast, 2019 – 2027
8.2.1.5. Compound Annual Growth Rate (CAGR)
8.2.1.6. Regional Bifurcation
8.2.1.6.1. North America
8.2.1.6.1.1.Market
Estimation, 2013 – 2018
8.2.1.6.1.2.Market
Forecast, 2019 – 2027
8.2.1.6.2. Europe
8.2.1.6.2.1.Market
Estimation, 2013 – 2018
8.2.1.6.2.2.Market
Forecast, 2019 – 2027
8.2.1.6.3. Asia Pacific
8.2.1.6.3.1.Market
Estimation, 2013 – 2018
8.2.1.6.3.2.Market
Forecast, 2019 – 2027
8.2.1.6.4. Middle East and Africa
8.2.1.6.4.1.Market
Estimation, 2013 – 2018
8.2.1.6.4.2.Market
Forecast, 2019 – 2027
8.2.1.6.5. Latin America
8.2.1.6.5.1.Market
Estimation, 2013 – 2018
8.2.1.6.5.2.Market
Forecast, 2019 – 2027
8.2.2. Static
8.2.2.1. Definition
8.2.2.2. Market Penetration, 2018
8.2.2.3. Market Estimation, 2013 – 2018
8.2.2.4. Market Forecast, 2019 – 2027
8.2.2.5. Compound Annual Growth Rate (CAGR)
8.2.2.6. Regional Bifurcation
8.2.2.6.1. North America
8.2.2.6.1.1.Market
Estimation, 2013 – 2018
8.2.2.6.1.2.Market
Forecast, 2019 – 2027
8.2.2.6.2. Europe
8.2.2.6.2.1.Market
Estimation, 2013 – 2018
8.2.2.6.2.2.Market
Forecast, 2019 – 2027
8.2.2.6.3. Asia Pacific
8.2.2.6.3.1.Market
Estimation, 2013 – 2018
8.2.2.6.3.2.Market
Forecast, 2019 – 2027
8.2.2.6.4. Middle East and Africa
8.2.2.6.4.1.Market
Estimation, 2013 – 2018
8.2.2.6.4.2.Market
Forecast, 2019 – 2027
8.2.2.6.5. Latin America
8.2.2.6.5.1.Market
Estimation, 2013 – 2018
8.2.2.6.5.2.Market
Forecast, 2019 – 2027
8.2.3. Hybrid
8.2.3.1. Definition
8.2.3.2. Market Penetration, 2018
8.2.3.3. Market Estimation, 2013 – 2018
8.2.3.4. Market Forecast, 2019 – 2027
8.2.3.5. Compound Annual Growth Rate (CAGR)
8.2.3.6. Regional Bifurcation
8.2.3.6.1. North America
8.2.3.6.1.1.Market
Estimation, 2013 – 2018
8.2.3.6.1.2.Market
Forecast, 2019 – 2027
8.2.3.6.2. Europe
8.2.3.6.2.1.Market
Estimation, 2013 – 2018
8.2.3.6.2.2.Market
Forecast, 2019 – 2027
8.2.3.6.3. Asia Pacific
8.2.3.6.3.1.Market
Estimation, 2013 – 2018
8.2.3.6.3.2.Market
Forecast, 2019 – 2027
8.2.3.6.4. Middle East and Africa
8.2.3.6.4.1.Market
Estimation, 2013 – 2018
8.2.3.6.4.2.Market
Forecast, 2019 – 2027
8.2.3.6.5. Latin America
8.2.3.6.5.1.Market
Estimation, 2013 – 2018
8.2.3.6.5.2.Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Systems
9. Global Telepathology Service Market Analysis and Forecasts,
2019 – 2027
9.1. Overview
9.2. Global
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Diagnosis
9.2.1.1. Definition
9.2.1.2. Market Penetration, 2018
9.2.1.3. Market Estimation, 2013 – 2018
9.2.1.4. Market Forecast, 2019 – 2027
9.2.1.5. Compound Annual Growth Rate (CAGR)
9.2.1.6. Regional Bifurcation
9.2.1.6.1. North America
9.2.1.6.1.1.Market
Estimation, 2013 – 2018
9.2.1.6.1.2.Market
Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1.Market
Estimation, 2013 – 2018
9.2.1.6.2.2.Market
Forecast, 2019 – 2027
9.2.1.6.3. Asia Pacific
9.2.1.6.3.1.Market
Estimation, 2013 – 2018
9.2.1.6.3.2.Market
Forecast, 2019 – 2027
9.2.1.6.4. Middle East and Africa
9.2.1.6.4.1.Market
Estimation, 2013 – 2018
9.2.1.6.4.2.Market
Forecast, 2019 – 2027
9.2.1.6.5. Latin America
9.2.1.6.5.1.Market
Estimation, 2013 – 2018
9.2.1.6.5.2.Market
Forecast, 2019 – 2027
9.2.2. Education
9.2.2.1. Definition
9.2.2.2. Market Penetration, 2018
9.2.2.3. Market Estimation, 2013 – 2018
9.2.2.4. Market Forecast, 2019 – 2027
9.2.2.5. Compound Annual Growth Rate (CAGR)
9.2.2.6. Regional Bifurcation
9.2.2.6.1. North America
9.2.2.6.1.1.Market
Estimation, 2013 – 2018
9.2.2.6.1.2.Market
Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1.Market
Estimation, 2013 – 2018
9.2.2.6.2.2.Market
Forecast, 2019 – 2027
9.2.2.6.3. Asia Pacific
9.2.2.6.3.1.Market
Estimation, 2013 – 2018
9.2.2.6.3.2.Market
Forecast, 2019 – 2027
9.2.2.6.4. Middle East and Africa
9.2.2.6.4.1.Market
Estimation, 2013 – 2018
9.2.2.6.4.2.Market
Forecast, 2019 – 2027
9.2.2.6.5. Latin America
9.2.2.6.5.1.Market
Estimation, 2013 – 2018
9.2.2.6.5.2.Market
Forecast, 2019 – 2027
9.2.3. Research
9.2.3.1. Definition
9.2.3.2. Market Penetration, 2018
9.2.3.3. Market Estimation, 2013 – 2018
9.2.3.4. Market Forecast, 2019 – 2027
9.2.3.5. Compound Annual Growth Rate (CAGR)
9.2.3.6. Regional Bifurcation
9.2.3.6.1. North America
9.2.3.6.1.1.Market
Estimation, 2013 – 2018
9.2.3.6.1.2.Market
Forecast, 2019 – 2027
9.2.3.6.2. Europe
9.2.3.6.2.1.Market
Estimation, 2013 – 2018
9.2.3.6.2.2.Market
Forecast, 2019 – 2027
9.2.3.6.3. Asia Pacific
9.2.3.6.3.1.Market
Estimation, 2013 – 2018
9.2.3.6.3.2.Market
Forecast, 2019 – 2027
9.2.3.6.4. Middle East and Africa
9.2.3.6.4.1.Market
Estimation, 2013 – 2018
9.2.3.6.4.2.Market
Forecast, 2019 – 2027
9.2.3.6.5. Latin America
9.2.3.6.5.1.Market
Estimation, 2013 – 2018
9.2.3.6.5.2.Market
Forecast, 2019 – 2027
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Penetration, 2018
9.2.4.3. Market Estimation, 2013 – 2018
9.2.4.4. Market Forecast, 2019 – 2027
9.2.4.5. Compound Annual Growth Rate (CAGR)
9.2.4.6. Regional Bifurcation
9.2.4.6.1. North America
9.2.4.6.1.1.Market
Estimation, 2013 – 2018
9.2.4.6.1.2.Market
Forecast, 2019 – 2027
9.2.4.6.2. Europe
9.2.4.6.2.1.Market
Estimation, 2013 – 2018
9.2.4.6.2.2.Market
Forecast, 2019 – 2027
9.2.4.6.3. Asia Pacific
9.2.4.6.3.1.Market
Estimation, 2013 – 2018
9.2.4.6.3.2.Market
Forecast, 2019 – 2027
9.2.4.6.4. Middle East and Africa
9.2.4.6.4.1.Market
Estimation, 2013 – 2018
9.2.4.6.4.2.Market
Forecast, 2019 – 2027
9.2.4.6.5. Latin America
9.2.4.6.5.1.Market
Estimation, 2013 – 2018
9.2.4.6.5.2.Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Telepathology Service Market Analysis and Forecasts,
2019 – 2027
10.1. Overview
10.2. Global
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market Penetration, 2018
10.2.1.3. Market Estimation, 2013 – 2018
10.2.1.4. Market Forecast, 2019 – 2027
10.2.1.5. Compound Annual Growth Rate (CAGR)
10.2.1.6. Regional Bifurcation
10.2.1.6.1. North America
10.2.1.6.1.1.Market
Estimation, 2013 – 2018
10.2.1.6.1.2.Market
Forecast, 2019 – 2027
10.2.1.6.2. Europe
10.2.1.6.2.1.Market
Estimation, 2013 – 2018
10.2.1.6.2.2.Market
Forecast, 2019 – 2027
10.2.1.6.3. Asia Pacific
10.2.1.6.3.1.Market
Estimation, 2013 – 2018
10.2.1.6.3.2.Market
Forecast, 2019 – 2027
10.2.1.6.4. Middle East and Africa
10.2.1.6.4.1.Market
Estimation, 2013 – 2018
10.2.1.6.4.2.Market
Forecast, 2019 – 2027
10.2.1.6.5. Latin America
10.2.1.6.5.1.Market
Estimation, 2013 – 2018
10.2.1.6.5.2.Market
Forecast, 2019 – 2027
10.2.2. Diagnostic
Centers and Pathology Clinics
10.2.2.1. Definition
10.2.2.2. Market Penetration, 2018
10.2.2.3. Market Estimation, 2013 – 2018
10.2.2.4. Market Forecast, 2019 – 2027
10.2.2.5. Compound Annual Growth Rate (CAGR)
10.2.2.6. Regional Bifurcation
10.2.2.6.1. North America
10.2.2.6.1.1.Market
Estimation, 2013 – 2018
10.2.2.6.1.2.Market
Forecast, 2019 – 2027
10.2.2.6.2. Europe
10.2.2.6.2.1.Market
Estimation, 2013 – 2018
10.2.2.6.2.2.Market
Forecast, 2019 – 2027
10.2.2.6.3. Asia Pacific
10.2.2.6.3.1.Market
Estimation, 2013 – 2018
10.2.2.6.3.2.Market
Forecast, 2019 – 2027
10.2.2.6.4. Middle East and Africa
10.2.2.6.4.1.Market
Estimation, 2013 – 2018
10.2.2.6.4.2.Market
Forecast, 2019 – 2027
10.2.2.6.5. Latin America
10.2.2.6.5.1.Market
Estimation, 2013 – 2018
10.2.2.6.5.2.Market
Forecast, 2019 – 2027
10.2.3. Pharmaceutical
and Biotech Companies
10.2.3.1. Definition
10.2.3.2. Market Penetration, 2018
10.2.3.3. Market Estimation, 2013 – 2018
10.2.3.4. Market Forecast, 2019 – 2027
10.2.3.5. Compound Annual Growth Rate (CAGR)
10.2.3.6. Regional Bifurcation
10.2.3.6.1. North America
10.2.3.6.1.1.Market
Estimation, 2013 – 2018
10.2.3.6.1.2.Market
Forecast, 2019 – 2027
10.2.3.6.2. Europe
10.2.3.6.2.1.Market
Estimation, 2013 – 2018
10.2.3.6.2.2.Market
Forecast, 2019 – 2027
10.2.3.6.3. Asia Pacific
10.2.3.6.3.1.Market
Estimation, 2013 – 2018
10.2.3.6.3.2.Market
Forecast, 2019 – 2027
10.2.3.6.4. Middle East and Africa
10.2.3.6.4.1.Market
Estimation, 2013 – 2018
10.2.3.6.4.2.Market
Forecast, 2019 – 2027
10.2.3.6.5. Latin America
10.2.3.6.5.1.Market
Estimation, 2013 – 2018
10.2.3.6.5.2.Market
Forecast, 2019 – 2027
10.2.4. Academic
Institutes
10.2.4.1. Definition
10.2.4.2. Market Penetration, 2018
10.2.4.3. Market Estimation, 2013 – 2018
10.2.4.4. Market Forecast, 2019 – 2027
10.2.4.5. Compound Annual Growth Rate (CAGR)
10.2.4.6. Regional Bifurcation
10.2.4.6.1. North America
10.2.4.6.1.1.Market
Estimation, 2013 – 2018
10.2.4.6.1.2.Market
Forecast, 2019 – 2027
10.2.4.6.2. Europe
10.2.4.6.2.1.Market
Estimation, 2013 – 2018
10.2.4.6.2.2.Market
Forecast, 2019 – 2027
10.2.4.6.3. Asia Pacific
10.2.4.6.3.1.Market
Estimation, 2013 – 2018
10.2.4.6.3.2.Market
Forecast, 2019 – 2027
10.2.4.6.4. Middle East and Africa
10.2.4.6.4.1.Market
Estimation, 2013 – 2018
10.2.4.6.4.2.Market
Forecast, 2019 – 2027
10.2.4.6.5. Latin America
10.2.4.6.5.1.Market
Estimation, 2013 – 2018
10.2.4.6.5.2.Market
Forecast, 2019 – 2027
10.2.5. Research
Organizations
10.2.5.1. Definition
10.2.5.2. Market Penetration, 2018
10.2.5.3. Market Estimation, 2013 – 2018
10.2.5.4. Market Forecast, 2019 – 2027
10.2.5.5. Compound Annual Growth Rate (CAGR)
10.2.5.6. Regional Bifurcation
10.2.5.6.1. North America
10.2.5.6.1.1.Market
Estimation, 2013 – 2018
10.2.5.6.1.2.Market
Forecast, 2019 – 2027
10.2.5.6.2. Europe
10.2.5.6.2.1.Market
Estimation, 2013 – 2018
10.2.5.6.2.2.Market
Forecast, 2019 – 2027
10.2.5.6.3. Asia Pacific
10.2.5.6.3.1.Market
Estimation, 2013 – 2018
10.2.5.6.3.2.Market
Forecast, 2019 – 2027
10.2.5.6.4. Middle East and Africa
10.2.5.6.4.1.Market
Estimation, 2013 – 2018
10.2.5.6.4.2.Market
Forecast, 2019 – 2027
10.2.5.6.5. Latin America
10.2.5.6.5.1.Market
Estimation, 2013 – 2018
10.2.5.6.5.2.Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By End
User
11. North America Telepathology Service Market Analysis and
Forecasts, 2019 - 2027
11.1. Overview
11.1.1. North
America Telepathology Service Market Revenue (US$ Mn)
11.2. North
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Systems
11.2.1. Dynamic
11.2.2. Static
11.2.3. Hybrid
11.3. North
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Diagnosis
11.3.2. Education
11.3.3. Research
11.3.4. Others
11.4. North
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.1. Hospitals
11.4.2. Diagnostic
Centers and Pathology Clinics
11.4.3. Pharmaceutical
and Biotech Companies
11.4.4. Academic
Institutes
11.4.5. Research
Organizations
11.5. North
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Telepathology Service Market Revenue (US$ Mn) and Forecasts,
By Systems
11.5.1.1.1. Dynamic
11.5.1.1.2. Static
11.5.1.1.3. Hybrid
11.5.1.2. U.S Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.1.2.1. Diagnosis
11.5.1.2.2. Education
11.5.1.2.3. Research
11.5.1.2.4. Others
11.5.1.3. U.S Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.1.3.1. Hospitals
11.5.1.3.2. Diagnostic Centers and Pathology Clinics
11.5.1.3.3. Pharmaceutical and Biotech Companies
11.5.1.3.4. Academic Institutes
11.5.1.3.5. Research Organizations
11.5.2. Canada
11.5.2.1. Canada Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
11.5.2.1.1. Dynamic
11.5.2.1.2. Static
11.5.2.1.3. Hybrid
11.5.2.2. Canada Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.2.2.1. Diagnosis
11.5.2.2.2. Education
11.5.2.2.3. Research
11.5.2.2.4. Others
11.5.2.3. Canada Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.2.3.1. Hospitals
11.5.2.3.2. Diagnostic Centers and Pathology Clinics
11.5.2.3.3. Pharmaceutical and Biotech Companies
11.5.2.3.4. Academic Institutes
11.5.2.3.5. Research Organizations
11.5.3. Mexico
11.5.3.1. Mexico Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
11.5.3.1.1. Dynamic
11.5.3.1.2. Static
11.5.3.1.3. Hybrid
11.5.3.2. Mexico Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.3.2.1. Diagnosis
11.5.3.2.2. Education
11.5.3.2.3. Research
11.5.3.2.4. Others
11.5.3.3. Mexico Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.3.3.1. Hospitals
11.5.3.3.2. Diagnostic Centers and Pathology Clinics
11.5.3.3.3. Pharmaceutical and Biotech Companies
11.5.3.3.4. Academic Institutes
11.5.3.3.5. Research Organizations
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By Systems
11.5.4.1.1. Dynamic
11.5.4.1.2. Static
11.5.4.1.3. Hybrid
11.5.4.2. Rest of North America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By Application
11.5.4.2.1. Diagnosis
11.5.4.2.2. Education
11.5.4.2.3. Research
11.5.4.2.4. Others
11.5.4.3. Rest of North America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By End User
11.5.4.3.1. Hospitals
11.5.4.3.2. Diagnostic Centers and Pathology Clinics
11.5.4.3.3. Pharmaceutical and Biotech Companies
11.5.4.3.4. Academic Institutes
11.5.4.3.5. Research Organizations
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Systems
11.6.3. By
Application
11.6.4. By End
User
12. Europe Telepathology Service Market Analysis and Forecasts,
2019 - 2027
12.1. Overview
12.1.1. Europe
Telepathology Service Market Revenue (US$ Mn)
12.2. Europe
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Systems
12.2.1. Dynamic
12.2.2. Static
12.2.3. Hybrid
12.3. Europe
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Diagnosis
12.3.2. Education
12.3.3. Research
12.3.4. Others
12.4. Europe
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1. Hospitals
12.4.2. Diagnostic
Centers and Pathology Clinics
12.4.3. Pharmaceutical
and Biotech Companies
12.4.4. Academic
Institutes
12.4.5. Research
Organizations
12.5. Europe
Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
12.5.1.1.1. Dynamic
12.5.1.1.2. Static
12.5.1.1.3. Hybrid
12.5.1.2. France Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.1.2.1. Diagnosis
12.5.1.2.2. Education
12.5.1.2.3. Research
12.5.1.2.4. Others
12.5.1.3. France Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
12.5.1.3.1. Hospitals
12.5.1.3.2. Diagnostic Centers and Pathology Clinics
12.5.1.3.3. Pharmaceutical and Biotech Companies
12.5.1.3.4. Academic Institutes
12.5.1.3.5. Research Organizations
12.5.2. The UK
12.5.2.1. The UK Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
12.5.2.1.1. Dynamic
12.5.2.1.2. Static
12.5.2.1.3. Hybrid
12.5.2.2. The UK Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.2.2.1. Diagnosis
12.5.2.2.2. Education
12.5.2.2.3. Research
12.5.2.2.4. Others
12.5.2.3. The UK Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
12.5.2.3.1. Hospitals
12.5.2.3.2. Diagnostic Centers and Pathology Clinics
12.5.2.3.3. Pharmaceutical and Biotech Companies
12.5.2.3.4. Academic Institutes
12.5.2.3.5. Research Organizations
12.5.3. Spain
12.5.3.1. Spain Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
12.5.3.1.1. Dynamic
12.5.3.1.2. Static
12.5.3.1.3. Hybrid
12.5.3.2. Spain Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.3.2.1. Diagnosis
12.5.3.2.2. Education
12.5.3.2.3. Research
12.5.3.2.4. Others
12.5.3.3. Spain Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
12.5.3.3.1. Hospitals
12.5.3.3.2. Diagnostic Centers and Pathology Clinics
12.5.3.3.3. Pharmaceutical and Biotech Companies
12.5.3.3.4. Academic Institutes
12.5.3.3.5. Research Organizations
12.5.4. Germany
12.5.4.1. Germany Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
12.5.4.1.1. Dynamic
12.5.4.1.2. Static
12.5.4.1.3. Hybrid
12.5.4.2. Germany Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.4.2.1. Diagnosis
12.5.4.2.2. Education
12.5.4.2.3. Research
12.5.4.2.4. Others
12.5.4.3. Germany Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
12.5.4.3.1. Hospitals
12.5.4.3.2. Diagnostic Centers and Pathology Clinics
12.5.4.3.3. Pharmaceutical and Biotech Companies
12.5.4.3.4. Academic Institutes
12.5.4.3.5. Research Organizations
12.5.5. Italy
12.5.5.1. Italy Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
12.5.5.1.1. Dynamic
12.5.5.1.2. Static
12.5.5.1.3. Hybrid
12.5.5.2. Italy Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.5.2.1. Diagnosis
12.5.5.2.2. Education
12.5.5.2.3. Research
12.5.5.2.4. Others
12.5.5.3. Italy Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
12.5.5.3.1. Hospitals
12.5.5.3.2. Diagnostic Centers and Pathology Clinics
12.5.5.3.3. Pharmaceutical and Biotech Companies
12.5.5.3.4. Academic Institutes
12.5.5.3.5. Research Organizations
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Systems
12.5.6.1.1. Dynamic
12.5.6.1.2. Static
12.5.6.1.3. Hybrid
12.5.6.2. Nordic Countries Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.6.2.1. Diagnosis
12.5.6.2.2. Education
12.5.6.2.3. Research
12.5.6.2.4. Others
12.5.6.3. Nordic Countries Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By End User
12.5.6.3.1. Hospitals
12.5.6.3.2. Diagnostic Centers and Pathology Clinics
12.5.6.3.3. Pharmaceutical and Biotech Companies
12.5.6.3.4. Academic Institutes
12.5.6.3.5. Research Organizations
12.5.6.4. Nordic Countries Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Systems
12.5.7.1.1. Dynamic
12.5.7.1.2. Static
12.5.7.1.3. Hybrid
12.5.7.2. Benelux Union Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.7.2.1. Diagnosis
12.5.7.2.2. Education
12.5.7.2.3. Research
12.5.7.2.4. Others
12.5.7.3. Benelux Union Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By End User
12.5.7.3.1. Hospitals
12.5.7.3.2. Diagnostic Centers and Pathology Clinics
12.5.7.3.3. Pharmaceutical and Biotech Companies
12.5.7.3.4. Academic Institutes
12.5.7.3.5. Research Organizations
12.5.7.4. Benelux Union Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Systems
12.5.8.1.1. Dynamic
12.5.8.1.2. Static
12.5.8.1.3. Hybrid
12.5.8.2. Rest of Europe Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.8.2.1. Diagnosis
12.5.8.2.2. Education
12.5.8.2.3. Research
12.5.8.2.4. Others
12.5.8.3. Rest of Europe Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By End User
12.5.8.3.1. Hospitals
12.5.8.3.2. Diagnostic Centers and Pathology Clinics
12.5.8.3.3. Pharmaceutical and Biotech Companies
12.5.8.3.4. Academic Institutes
12.5.8.3.5. Research Organizations
12.6. Key
Segment for Channeling Investments
12.6.1. By Country
12.6.2. By
Systems
12.6.3. By
Application
12.6.4. By End
User
13. Asia Pacific Telepathology Service Market Analysis and
Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Asia
Pacific Telepathology Service Market Revenue (US$ Mn)
13.2. Asia
Pacific Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Systems
13.2.1. Dynamic
13.2.2. Static
13.2.3. Hybrid
13.3. Asia
Pacific Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Application
13.3.1. Diagnosis
13.3.2. Education
13.3.3. Research
13.3.4. Others
13.4. Asia
Pacific Telepathology Service Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.1. Hospitals
13.4.2. Diagnostic
Centers and Pathology Clinics
13.4.3. Pharmaceutical
and Biotech Companies
13.4.4. Academic
Institutes
13.4.5. Research
Organizations
13.5. Asia
Pacific Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.1.1.1. Dynamic
13.5.1.1.2. Static
13.5.1.1.3. Hybrid
13.5.1.2. China Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.1.2.1. Diagnosis
13.5.1.2.2. Education
13.5.1.2.3. Research
13.5.1.2.4. Others
13.5.1.3. China Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.1.3.1. Hospitals
13.5.1.3.2. Diagnostic Centers and Pathology Clinics
13.5.1.3.3. Pharmaceutical and Biotech Companies
13.5.1.3.4. Academic Institutes
13.5.1.3.5. Research Organizations
13.5.2. Japan
13.5.2.1. Japan Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.2.1.1. Dynamic
13.5.2.1.2. Static
13.5.2.1.3. Hybrid
13.5.2.2. Japan Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.2.2.1. Diagnosis
13.5.2.2.2. Education
13.5.2.2.3. Research
13.5.2.2.4. Others
13.5.2.3. Japan Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.2.3.1. Hospitals
13.5.2.3.2. Diagnostic Centers and Pathology Clinics
13.5.2.3.3. Pharmaceutical and Biotech Companies
13.5.2.3.4. Academic Institutes
13.5.2.3.5. Research Organizations
13.5.3. India
13.5.3.1. India Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.3.1.1. Dynamic
13.5.3.1.2. Static
13.5.3.1.3. Hybrid
13.5.3.2. India Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.3.2.1. Diagnosis
13.5.3.2.2. Education
13.5.3.2.3. Research
13.5.3.2.4. Others
13.5.3.3. India Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.3.3.1. Hospitals
13.5.3.3.2. Diagnostic Centers and Pathology Clinics
13.5.3.3.3. Pharmaceutical and Biotech Companies
13.5.3.3.4. Academic Institutes
13.5.3.3.5. Research Organizations
13.5.4. New
Zealand
13.5.4.1. New Zealand Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.4.1.1. Dynamic
13.5.4.1.2. Static
13.5.4.1.3. Hybrid
13.5.4.2. New Zealand Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.4.2.1. Diagnosis
13.5.4.2.2. Education
13.5.4.2.3. Research
13.5.4.2.4. Others
13.5.4.3. New Zealand Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.4.3.1. Hospitals
13.5.4.3.2. Diagnostic Centers and Pathology Clinics
13.5.4.3.3. Pharmaceutical and Biotech Companies
13.5.4.3.4. Academic Institutes
13.5.4.3.5. Research Organizations
13.5.5. Australia
13.5.5.1. Australia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.5.1.1. Dynamic
13.5.5.1.2. Static
13.5.5.1.3. Hybrid
13.5.5.2. Australia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.5.2.1. Diagnosis
13.5.5.2.2. Education
13.5.5.2.3. Research
13.5.5.2.4. Others
13.5.5.3. Australia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.5.3.1. Hospitals
13.5.5.3.2. Diagnostic Centers and Pathology Clinics
13.5.5.3.3. Pharmaceutical and Biotech Companies
13.5.5.3.4. Academic Institutes
13.5.5.3.5. Research Organizations
13.5.6. South
Korea
13.5.6.1. South Korea Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
13.5.6.1.1. Dynamic
13.5.6.1.2. Static
13.5.6.1.3. Hybrid
13.5.6.2. South Korea Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.6.2.1. Diagnosis
13.5.6.2.2. Education
13.5.6.2.3. Research
13.5.6.2.4. Others
13.5.6.3. South Korea Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.6.3.1. Hospitals
13.5.6.3.2. Diagnostic Centers and Pathology Clinics
13.5.6.3.3. Pharmaceutical and Biotech Companies
13.5.6.3.4. Academic Institutes
13.5.6.3.5. Research Organizations
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Systems
13.5.7.1.1. Dynamic
13.5.7.1.2. Static
13.5.7.1.3. Hybrid
13.5.7.2. Southeast Asia Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.7.2.1. Diagnosis
13.5.7.2.2. Education
13.5.7.2.3. Research
13.5.7.2.4. Others
13.5.7.3. Southeast Asia Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By End User
13.5.7.3.1. Hospitals
13.5.7.3.2. Diagnostic Centers and Pathology Clinics
13.5.7.3.3. Pharmaceutical and Biotech Companies
13.5.7.3.4. Academic Institutes
13.5.7.3.5. Research Organizations
13.5.7.4. Southeast Asia Telepathology Service Market Revenue (US$ Mn)
and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Telepathology Service Market Revenue (US$
Mn) and Forecasts, By Systems
13.5.8.1.1. Dynamic
13.5.8.1.2. Static
13.5.8.1.3. Hybrid
13.5.8.2. Rest of Asia Pacific Telepathology Service Market Revenue (US$
Mn) and Forecasts, By Application
13.5.8.2.1. Diagnosis
13.5.8.2.2. Education
13.5.8.2.3. Research
13.5.8.2.4. Others
13.5.8.3. Rest of Asia Pacific Telepathology Service Market Revenue (US$
Mn) and Forecasts, By End User
13.5.8.3.1. Hospitals
13.5.8.3.2. Diagnostic Centers and Pathology Clinics
13.5.8.3.3. Pharmaceutical and Biotech Companies
13.5.8.3.4. Academic Institutes
13.5.8.3.5. Research Organizations
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Systems
13.6.3. By Application
13.6.4. By End
User
14. Middle East and Africa Telepathology Service Market Analysis
and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa Telepathology Service Market Revenue (US$ Mn)
14.2. Middle
East and Africa Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Systems
14.2.1. Dynamic
14.2.2. Static
14.2.3. Hybrid
14.3. Middle
East and Africa Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Diagnosis
14.3.2. Education
14.3.3. Research
14.3.4. Others
14.4. Middle
East and Africa Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
End User
14.4.1. Hospitals
14.4.2. Diagnostic
Centers and Pathology Clinics
14.4.3. Pharmaceutical
and Biotech Companies
14.4.4. Academic
Institutes
14.4.5. Research
Organizations
14.5. Middle
East and Africa Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
14.5.1.1.1. Dynamic
14.5.1.1.2. Static
14.5.1.1.3. Hybrid
14.5.1.2. Saudi Arabia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.1.2.1. Diagnosis
14.5.1.2.2. Education
14.5.1.2.3. Research
14.5.1.2.4. Others
14.5.1.3. Saudi Arabia Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.1.3.1. Hospitals
14.5.1.3.2. Diagnostic Centers and Pathology Clinics
14.5.1.3.3. Pharmaceutical and Biotech Companies
14.5.1.3.4. Academic Institutes
14.5.1.3.5. Research Organizations
14.5.2. UAE
14.5.2.1. UAE Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
14.5.2.1.1. Dynamic
14.5.2.1.2. Static
14.5.2.1.3. Hybrid
14.5.2.2. UAE Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.2.2.1. Diagnosis
14.5.2.2.2. Education
14.5.2.2.3. Research
14.5.2.2.4. Others
14.5.2.3. UAE Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.2.3.1. Hospitals
14.5.2.3.2. Diagnostic Centers and Pathology Clinics
14.5.2.3.3. Pharmaceutical and Biotech Companies
14.5.2.3.4. Academic Institutes
14.5.2.3.5. Research Organizations
14.5.3. Egypt
14.5.3.1. Egypt Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
14.5.3.1.1. Dynamic
14.5.3.1.2. Static
14.5.3.1.3. Hybrid
14.5.3.2. Egypt Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.3.2.1. Diagnosis
14.5.3.2.2. Education
14.5.3.2.3. Research
14.5.3.2.4. Others
14.5.3.3. Egypt Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.3.3.1. Hospitals
14.5.3.3.2. Diagnostic Centers and Pathology Clinics
14.5.3.3.3. Pharmaceutical and Biotech Companies
14.5.3.3.4. Academic Institutes
14.5.3.3.5. Research Organizations
14.5.4. Kuwait
14.5.4.1. Kuwait Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
14.5.4.1.1. Dynamic
14.5.4.1.2. Static
14.5.4.1.3. Hybrid
14.5.4.2. Kuwait Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.4.2.1. Diagnosis
14.5.4.2.2. Education
14.5.4.2.3. Research
14.5.4.2.4. Others
14.5.4.3. Kuwait Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.4.3.1. Hospitals
14.5.4.3.2. Diagnostic Centers and Pathology Clinics
14.5.4.3.3. Pharmaceutical and Biotech Companies
14.5.4.3.4. Academic Institutes
14.5.4.3.5. Research Organizations
14.5.5. South
Africa
14.5.5.1. South Africa Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
14.5.5.1.1. Dynamic
14.5.5.1.2. Static
14.5.5.1.3. Hybrid
14.5.5.2. South Africa Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.5.2.1. Diagnosis
14.5.5.2.2. Education
14.5.5.2.3. Research
14.5.5.2.4. Others
14.5.5.3. South Africa Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.5.3.1. Hospitals
14.5.5.3.2. Diagnostic Centers and Pathology Clinics
14.5.5.3.3. Pharmaceutical and Biotech Companies
14.5.5.3.4. Academic Institutes
14.5.5.3.5. Research Organizations
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Telepathology Service Market
Revenue (US$ Mn) and Forecasts, By Systems
14.5.6.1.1. Dynamic
14.5.6.1.2. Static
14.5.6.1.3. Hybrid
14.5.6.2. Rest of Middle East & Africa Telepathology Service Market
Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1. Diagnosis
14.5.6.2.2. Education
14.5.6.2.3. Research
14.5.6.2.4. Others
14.5.6.3. Rest of Middle East & Africa Telepathology Service Market
Revenue (US$ Mn) and Forecasts, By End User
14.5.6.3.1. Hospitals
14.5.6.3.2. Diagnostic Centers and Pathology Clinics
14.5.6.3.3. Pharmaceutical and Biotech Companies
14.5.6.3.4. Academic Institutes
14.5.6.3.5. Research Organizations
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Systems
14.6.3. By
Application
14.6.4. By End
User
15. Latin America Telepathology Service Market Analysis and
Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Latin
America Telepathology Service Market Revenue (US$ Mn)
15.2. Latin
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Systems
15.2.1. Dynamic
15.2.2. Static
15.2.3. Hybrid
15.3. Latin
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By
Application
15.3.1. Diagnosis
15.3.2. Education
15.3.3. Research
15.3.4. Others
15.4. Latin
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By End
User
15.4.1. Hospitals
15.4.2. Diagnostic
Centers and Pathology Clinics
15.4.3. Pharmaceutical
and Biotech Companies
15.4.4. Academic
Institutes
15.4.5. Research
Organizations
15.5. Latin
America Telepathology Service Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
15.5.1.1.1. Dynamic
15.5.1.1.2. Static
15.5.1.1.3. Hybrid
15.5.1.2. Brazil Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.1.2.1. Diagnosis
15.5.1.2.2. Education
15.5.1.2.3. Research
15.5.1.2.4. Others
15.5.1.3. Brazil Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
15.5.1.3.1. Hospitals
15.5.1.3.2. Diagnostic Centers and Pathology Clinics
15.5.1.3.3. Pharmaceutical and Biotech Companies
15.5.1.3.4. Academic Institutes
15.5.1.3.5. Research Organizations
15.5.2. Argentina
15.5.2.1. Argentina Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Systems
15.5.2.1.1. Dynamic
15.5.2.1.2. Static
15.5.2.1.3. Hybrid
15.5.2.2. Argentina Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.2.2.1. Diagnosis
15.5.2.2.2. Education
15.5.2.2.3. Research
15.5.2.2.4. Others
15.5.2.3. Argentina Telepathology Service Market Revenue (US$ Mn) and
Forecasts, By End User
15.5.2.3.1. Hospitals
15.5.2.3.2. Diagnostic Centers and Pathology Clinics
15.5.2.3.3. Pharmaceutical and Biotech Companies
15.5.2.3.4. Academic Institutes
15.5.2.3.5. Research Organizations
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By Systems
15.5.3.1.1. Dynamic
15.5.3.1.2. Static
15.5.3.1.3. Hybrid
15.5.3.2. Rest of Latin America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By Application
15.5.3.2.1. Diagnosis
15.5.3.2.2. Education
15.5.3.2.3. Research
15.5.3.2.4. Others
15.5.3.3. Rest of Latin America Telepathology Service Market Revenue
(US$ Mn) and Forecasts, By End User
15.5.3.3.1. Hospitals
15.5.3.3.2. Diagnostic Centers and Pathology Clinics
15.5.3.3.3. Pharmaceutical and Biotech Companies
15.5.3.3.4. Academic Institutes
15.5.3.3.5. Research Organizations
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Systems
15.6.3. By
Application
15.6.4. By End
User
16. Competitive Benchmarking
16.1. Brand
Benchmarking
16.2. Market
Share Analysis, 2018
16.3. Global
Presence and Growth Strategies
16.3.1. Mergers
and Acquisitions
16.3.2. Product
Launches
16.3.3. Investments
Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Apollo
Tele Health Services
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Diagnostic
Instruments, Inc.
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. eVisit
Telemedicine Solution
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. F.Hoffmann-LaRocheLtd
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. General
Electric Company
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Leica
Biosystems Nussloch GmbH
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Meyer
Instruments Inc.
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. OLYMPUS
CORPORATION
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Remote
Medical Technologies, LLC
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. SRL
Diagnostics
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Teleconsult
Europe
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. UNILABS
SA
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. Washington
University in St.Louis
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business Strategies
17.14. Other
Industry Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
